Primary non-adherence to bisphosphonates in an integrated healthcare setting

[11] Blau EM(2012)Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders J Gen Intern Med 27 57-64

[12] Cook PF(2009)Long-term medication adherence after myocardial infarction: experience of a community Am J Med 122 967-913

[13] Emiliozzi S(2009)Factors associated with first-fill adherence rates for diabetic medications: a cohort study J Gen Intern Med 24 233-237

[14] McCabe MM(2010)Determinants of primary nonadherence in asthama-controller and dyslipidemia pharmacotherapy Am J Pharm Benefits 2 111-118

[15] Greenwald B(2006)Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis Maturitas 55 227-237

[16] Bardwell A(2001)Health beliefs and attitudes toward the prevention of osteoporosis in older women Menopause 8 372-376

[17] Malinak J(2011)Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008 Health Expect 14 307-320

[18] Rude R(2006)Patient preference in the management of postmenopausal osteoporosis with bisphosphonates Clin Interv Aging 1 415-423

[19] Silverman SL(2011)Why do women reject bisphosphonates for osteoporosis? A videographic study PLoS One 6 e18468-1821

[20] White-Greenwald M(2008)Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs J Gen Intern Med 23 1815-1826

[11] Blau EM(2012)Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders J Gen Intern Med 27 57-64

[12] Cook PF(2009)Long-term medication adherence after myocardial infarction: experience of a community Am J Med 122 967-913

[13] Emiliozzi S(2009)Factors associated with first-fill adherence rates for diabetic medications: a cohort study J Gen Intern Med 24 233-237

[14] McCabe MM(2010)Determinants of primary nonadherence in asthama-controller and dyslipidemia pharmacotherapy Am J Pharm Benefits 2 111-118

[15] Greenwald B(2006)Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis Maturitas 55 227-237

[16] Bardwell A(2001)Health beliefs and attitudes toward the prevention of osteoporosis in older women Menopause 8 372-376

[17] Malinak J(2011)Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008 Health Expect 14 307-320

[18] Rude R(2006)Patient preference in the management of postmenopausal osteoporosis with bisphosphonates Clin Interv Aging 1 415-423

[19] Silverman SL(2011)Why do women reject bisphosphonates for osteoporosis? A videographic study PLoS One 6 e18468-1821

[20] White-Greenwald M(2008)Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs J Gen Intern Med 23 1815-1826